Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRRC45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UNC45A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLIPR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SETX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR2H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM168 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM192A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCYOX1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ING1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INPP4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REPS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INPP5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKIB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIS3L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on